These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4846987)

  • 1. [Role of antibiotics in complex treatment of ulcer disease].
    ArtemIev EN; Sanina AZ
    Sov Med; 1974 Mar; 37(3):51-3. PubMed ID: 4846987
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antirecurrence treatment of ulcer disease with methyluracil and nerobol].
    Lomazova MM
    Vrach Delo; 1973 Jan; 1():56-7. PubMed ID: 4722287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with the complex treatment of peptic ulcer by a combination of anticholinergic and anabolic agents].
    Chernov AP
    Sov Med; 1972 Aug; 35(8):104-8. PubMed ID: 5070524
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of protein hydrolysates and anabolic steroids in the complex treatment of patients with ulcer disease].
    Spivak AM
    Vrach Delo; 1973 Oct; 10():3-7. PubMed ID: 4783297
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prophylaxis of aggravation of peptic ulcer and chronic gastritis].
    Dovgiallo OG; Eĭnysh AA
    Klin Med (Mosk); 1973 Oct; 51(10):54-7. PubMed ID: 4787280
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of peptic ulcer with anabolic steroids].
    Deĭneko NF; Shustval' NF; Ikhnenko RI; Bakumenko IS
    Klin Med (Mosk); 1973 Oct; 51(10):57-63. PubMed ID: 4787281
    [No Abstract]   [Full Text] [Related]  

  • 7. [The drug prophylaxis of peptic ulcer exacerbations].
    Grigor'ev PIa; Iakovenko EP; Agafonova NA; Prianishnikova AS; Soluianova IP; Iakovenko AV; Vasil'ev IV; Agrba VZ; Stepanov AV; Kolodkin AM
    Ter Arkh; 1995; 67(2):26-9. PubMed ID: 7725253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Economic effectiveness of antirecurrence treatment of peptic ulcer].
    Lomazova MM; Kabkalo DN
    Vrach Delo; 1976 Sep; (9):91-2. PubMed ID: 824821
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of gastric and duodenal ulcers with methyluracil (methacil)].
    Kapitanenko AM
    Sov Med; 1968 Jun; 31(6):140-1. PubMed ID: 5741585
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
    Fedotin MS
    Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving therapies for peptic ulcer disease: Helicobacter pylori treatment.
    Cohen JC
    Gastroenterologist; 1995 Dec; 3(4):289-300. PubMed ID: 8775091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of Helicobacter pylori infection. Its relationship with gastrointestinal ulcer and antimicrobial resistance].
    Antelo P; Almuzara M; Avagnina A; Topor J; Barberis C; Barcia T; Araujo G; Vay C; Famiglietti A
    Medicina (B Aires); 2001; 61(5 Pt 1):545-51. PubMed ID: 11721321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection.
    Gabryelewicz A
    J Physiol Pharmacol; 1996 Mar; 47(1):51-8. PubMed ID: 8777307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of infectious agents in peptic ulcers and gastritis.
    Ir Med J; 1993 Jan; 86(1):9. PubMed ID: 8444607
    [No Abstract]   [Full Text] [Related]  

  • 18. [Eradication therapy of Helicobacter pylori--associated diseases: efficacy, safety, pharmacoeconomy].
    Grinevich VB; Sablin OA; Gubonina IV; Dobrenko VA
    Eksp Klin Gastroenterol; 2005; (2):95-9. PubMed ID: 15932163
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is a 1-week treatment enough and safe for the healing of peptic ulcer?].
    Pajares JM; Gisbert JP
    Rev Esp Enferm Dig; 2000 Jan; 92(1):1-4. PubMed ID: 10758728
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of nerobol and aminokrovin on the free amino acid content in peptic ulcer].
    Komarov FI; Lisovskiĭ VA; Lisovskiĭ IV; Shchedrunov VV
    Sov Med; 1973 May; 36(5):83-7. PubMed ID: 4768352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.